Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis
NCT ID: NCT06331390
Last Updated: 2024-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
25 participants
INTERVENTIONAL
2024-04-30
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Regional Differences of Cutaneous Irritation and Its Effect on Skin Barrier Recovery
NCT03231813
Glycyrrhetinic Acid and Acute Irritant Dermatitis
NCT07286487
Evaluation of Cicaplast in Subjects With Skin Irritation
NCT05767333
Epicutaneous Testing of Cosmetics for Skin Compatibility
NCT03024671
Impact of Exposure to Cosmetics on Sensitive Skin
NCT03958968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervenition
immortela cosmetic product
niacinamide cosmetic product
immortella skincare product
placebo
nothing
placebo
nothing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
niacinamide cosmetic product
immortella skincare product
placebo
nothing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Split, School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dario Leskur
assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
JOSIPA BUKIĆ
Role: PRINCIPAL_INVESTIGATOR
USSM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Split School of Medicine
Split, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2181-198-03-04-24-0008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.